Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Total Current Liabilities

$8.02M

Quarterly · Period ending: · USD

LCTX logo

LCTX Total Current Liabilities

Latest reported$8.02M
LCTX Quarterly Current Liabilities ($200.00K → $8.02M)
High-resolution chart · PNG

LCTX total current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Total Current Liabilities — Quarterly (USD)
Period endingTotal Current Liabilities (USD)
830,561
136,433
359,749
113,915
308,170
127,355
595,512
500,000
300,000
300,000
400,000
600,000
800,000
800,000
1,200,000
1,300,000
100,000
100,000
200,000
100,000
100,000
300,000
100,000
0
100,000
0
100,000
100,000
0
0
0
100,000
100,000
200,000
200,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.